e-Therapeutics plc (ETX) Ordinary 0.1p
- Add to watchlist
- Create an alert
- This stock can be held in a
11.15p
11.49p
24.00p
£65.15 million
11.15p
11.49p
8.00p
n/a
0.58p (4.90%) Previous:
0.58p
8,656
n/a
30,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/01/2023 | 31/01/2022 |
---|---|---|
Revenue (£m) | 0.47 | 0.48 |
Profit before tax (£m) | (9.77) | (9.52) |
Adjusted EPS (p): | (1.54) | (1.65) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
E-Therapeutics enters collaboration with Arcturis Data
2 November 2023 14:32
-
Eight new patent applications filed by e-therapeutics
1 August 2022 13:29
-
E-therapeutics reaches 'key milestone' in Galapagos collaboration
12 April 2022 13:26
-
Total Voting Rights
31 January 2024 16:30
-
Exercise of Options and Issue of Equity
24 January 2024 10:04
-
Business Update
16 January 2024 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.